Try our Advanced Search for more refined results

May 31, 2013

United States of America, et al., ex. rel. Charles Arnstein and Hossam Senousy v. Teva Pharmaceuticals USA, Inc., et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 06, 2020

    Teva To Pay $54M To End FCA Suit Alleging Bribes To Doctors

    Teva Pharmaceuticals has agreed to pony up $54 million to resolve a False Claims Act case accusing it of using speaker events to bribe doctors to prescribe two of its drugs, attorneys for two whistleblowers who brought the suit announced Monday.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login